THYROCARE.NS

Thyrocare Technologies Limited [THYROCARE.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

THYROCARE.NS Stock Summary

Top 10 Correlated Stocks

THYROCARE.NS

In the News

THYROCARE.NS Financial details

Company Rating
-
Market Cap
32.97B
Income
654.7M
Revenue
5.54B
Book val./share
-
Cash/share
-
Dividend
18
Dividend %
2.65%
Employees
1.65K
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
55.38
Forward P/E
-
PEG
-8.82
P/S
6.58
P/B
7.4
P/C
-
P/FCF
169.93
Quick Ratio
2.34
Current Ratio
3.05
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
12.39
EPS next Y
-
EPS next Q
-
EPS this Y
-63.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.28%
Revenue last 5Y
5.5%
Revenue Q/Q
-8.96%
EPS Q/Q
-24.48%
-
-
-
-
SMA20
14.06%
SMA50
5.87%
SMA100
-17.71%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
17%
ROC
0.18%
Gross Margin
70%
Oper. Margin
17%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
433.0-722.65
52W High
+21.62%
52W Low
+102.79%
RSI
68.52
Rel Volume
0.68
Avg Volume
111.49K
Volume
75.4K
Perf Week
20.12%
Perf Month
30%
Perf Quarter
-5.35%
Perf Half Y
-5.53%
-
-
-
-
Beta
0.522
-
-
Volatility
51.11%, 66.9%
Prev Close
-1.36%
Price
878.1
Change
-1.69%

THYROCARE.NS Financial Performance

THYROCARE.NS Dividend History

THYROCARE.NS Frequently Asked Questions

What is Thyrocare Technologies Limited stock symbol ?

Thyrocare Technologies Limited is a IN stock and trading under the symbol THYROCARE.NS

What is Thyrocare Technologies Limited stock quote today ?

Thyrocare Technologies Limited stock price is $878.1 today.

Is Thyrocare Technologies Limited stock public?

Yes, Thyrocare Technologies Limited is a publicly traded company.

Something similar

Top by Market Cap
MSFT
0YXG.L
AMZ.DE
VTSAX
BRH.DE
Same Sector
000705.SZ
CLIN.L
SYNGENE.NS
DXCM
LUN.CO
Top Correlated Stocks
BIL.NS
URJA.NS
SADBHAV.NS
INDBANK.NS
INDIANCARD.NS
Similar Market Cap
7888.T
600968.SS
0GZV.IL
GRMN
RQFI.L

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 111.49K
  • Market Capitalization 32.97B
  • Employee 1.65K
  • CEO Mr. Rahul Franklin Guha
  • Headquarters Navi Mumbai,IN
  • IPO Date 2016-05-10
  • Website https://www.thyrocare.com

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.